Literature DB >> 20004363

Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies.

Dorota Maciag1, Jonathan Hughes, Gillian O'Dwyer, Yilianys Pride, Craig A Stockmeier, Gerard Sanacora, Grazyna Rajkowska.   

Abstract

BACKGROUND: Several lines of evidence suggest dysfunction of the gamma-aminobutyric acid (GABA)ergic system in major depressive disorder. Neuroimaging studies report reduced levels of GABA in the dorsolateral prefrontal and occipital cortex of depressed patients. Our previous postmortem study revealed a reduction in the density and size of calbindin-immunoreactive (CB-IR) GABAergic neurons in the prefrontal cortex in major depressive disorder. The goal of this study was to test whether the changes in CB-IR neurons can also be detected in the occipital cortex, where neuroimaging studies report a prominent GABA decrease.
METHODS: A three-dimensional cell counting probe was used to assess the cell-packing density and size of CB-IR neurons in layer II of the occipital cortex in 10 major depressive disorder subjects and 10 psychiatrically healthy control subjects.
RESULTS: The density of CB-IR neurons was significantly decreased by 28% in major depressive disorder subjects compared with the control group. The size of CB-IR neurons was unchanged in major depressive disorder subjects when compared with control subjects.
CONCLUSIONS: The reduction in the density of CB-IR GABAergic neurons in the occipital cortex in depression is similar to that observed previously in the prefrontal cortex. Deficit in cortical GABAergic interneurons may contribute to the low GABA levels detected in neuroimaging studies in major depressive disorder patients. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004363      PMCID: PMC2823848          DOI: 10.1016/j.biopsych.2009.10.027

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  26 in total

1.  GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.

Authors:  Grazyna Rajkowska; Gillian O'Dwyer; Zsofia Teleki; Craig A Stockmeier; Jose Javier Miguel-Hidalgo
Journal:  Neuropsychopharmacology       Date:  2006-10-25       Impact factor: 7.853

2.  Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking.

Authors:  Graeme F Mason; Ismene L Petrakis; Robin A de Graaf; Ralitza Gueorguieva; Elizabeth Guidone; Vladimir Coric; C Neill Epperson; Douglas L Rothman; John H Krystal
Journal:  Biol Psychiatry       Date:  2005-11-14       Impact factor: 13.382

3.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo; J Wei; G Dilley; S D Pittman; H Y Meltzer; J C Overholser; B L Roth; C A Stockmeier
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

4.  An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study.

Authors:  Alexander McGirr; Johanne Renaud; Monique Seguin; Martin Alda; Chawki Benkelfat; Alain Lesage; Gustavo Turecki
Journal:  J Affect Disord       Date:  2006-07-18       Impact factor: 4.839

Review 5.  GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action.

Authors:  Gerard Sanacora; Aybala Saricicek
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-04       Impact factor: 4.388

6.  GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.

Authors:  S Hossein Fatemi; S Hossein Fatemi; Joel M Stary; Julie A Earle; Mohsen Araghi-Niknam; Elisabeth Eagan
Journal:  Schizophr Res       Date:  2005-01-01       Impact factor: 4.939

7.  Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

Authors:  Gregor Hasler; Jan Willem van der Veen; Toni Tumonis; Noah Meyers; Jun Shen; Wayne C Drevets
Journal:  Arch Gen Psychiatry       Date:  2007-02

8.  Alterations of P300 wave in occipital lobe in depressive patients.

Authors:  J Coullaut-Valera García; I Arbaiza Díaz del Rio; R Coullaut-Valera García; T Ortiz
Journal:  Actas Esp Psiquiatr       Date:  2007 Jul-Aug       Impact factor: 1.196

9.  Cerebral blood flow in immediate and sustained anxiety.

Authors:  Gregor Hasler; Stephen Fromm; Ruben P Alvarez; David A Luckenbaugh; Wayne C Drevets; Christian Grillon
Journal:  J Neurosci       Date:  2007-06-06       Impact factor: 6.167

10.  Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects.

Authors:  Zubin Bhagwagar; Marzena Wylezinska; Peter Jezzard; John Evans; Fiona Ashworth; Akeem Sule; Paul M Matthews; Philip J Cowen
Journal:  Biol Psychiatry       Date:  2007-01-08       Impact factor: 13.382

View more
  63 in total

1.  Prenatal dexamethasone selectively decreases calretinin expression in the adult female lateral amygdala.

Authors:  Damian G Zuloaga; David L Carbone; Robert J Handa
Journal:  Neurosci Lett       Date:  2012-06-02       Impact factor: 3.046

2.  Dexamethasone induces apoptosis in the developing rat amygdala in an age-, region-, and sex-specific manner.

Authors:  D G Zuloaga; D L Carbone; R Hiroi; D L Chong; R J Handa
Journal:  Neuroscience       Date:  2011-10-01       Impact factor: 3.590

3.  Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?

Authors:  David T Plante; J Eric Jensen; Laura Schoerning; John W Winkelman
Journal:  Neuropsychopharmacology       Date:  2012-02-08       Impact factor: 7.853

4.  Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.

Authors:  Marc J Dubin; Xiangling Mao; Samprit Banerjee; Zachary Goodman; Kyle A B Lapidus; Guoxin Kang; Conor Liston; Dikoma C Shungu
Journal:  J Psychiatry Neurosci       Date:  2016-04       Impact factor: 6.186

5.  GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.

Authors:  Etienne Sibille; Harvey M Morris; Rama S Kota; David A Lewis
Journal:  Int J Neuropsychopharmacol       Date:  2011-07       Impact factor: 5.176

6.  Glial fibrillary acidic protein is differentially expressed across cortical and subcortical regions in healthy brains and downregulated in the thalamus and caudate nucleus of depressed suicides.

Authors:  S G Torres-Platas; C Nagy; M Wakid; G Turecki; N Mechawar
Journal:  Mol Psychiatry       Date:  2015-06-02       Impact factor: 15.992

7.  SIRT1 rs3758391 and Major Depressive Disorder: New Data and Meta-Analysis.

Authors:  Wei Tang; Yan Chen; Xinyu Fang; Yewei Wang; Weixing Fan; Chen Zhang
Journal:  Neurosci Bull       Date:  2018-05-22       Impact factor: 5.203

8.  Network-Guided Transcranial Magnetic Stimulation for Depression.

Authors:  Marc J Dubin; Conor Liston; Michael A Avissar; Irena Ilieva; Faith M Gunning
Journal:  Curr Behav Neurosci Rep       Date:  2017-02-07

Review 9.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

10.  The cumulative effect of genetic polymorphisms on depression and brain structural integrity.

Authors:  Milutin Kostic; Elisa Canu; Federica Agosta; Ana Munjiza; Ivana Novakovic; Valerija Dobricic; Pilar Maria Ferraro; Vera Miler Jerkovic; Tatjana Pekmezovic; Dusica Lecic Tosevski; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2016-03-09       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.